|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net Income Loss | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangibles | |||||
| Asset impairment and related charges | |||||
| Impairment of goodwill | |||||
| Stock-based compensation | |||||
| Amortization of convertible debt discount | |||||
| Amortization of warrant | |||||
| Foreign currency remeasurement | |||||
| Deferred income taxes, net | |||||
| Provision for expected credit losses and returns | |||||
| Provision for excess and obsolete inventories | |||||
| Gain on sale of investment in equity securities | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Deferred revenues | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of investments | |||||
| Proceeds from maturities of investments | |||||
| Proceeds from sales of equity investments | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from long-term debt | |||||
| Repayment of convertible debt | |||||
| Payments for debt issuance costs | |||||
| Proceeds from other borrowings | |||||
| Repayment of long-term debt and other borrowings | |||||
| Repurchase of common stock | |||||
| Proceeds from common stock issued to employees | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of the year | |||||
| Cash and cash equivalents and restricted cash, end of the year | |||||
| Supplemental cash flow disclosure: | |||||
| Income tax payments, net | |||||
| Interest payments, net | |||||
| Supplemental schedule of non-cash investing activities: | |||||
| Capital expenditures incurred but not yet paid | |||||
| Supplemental schedule of non-cash financing activities: | |||||
| Shares of common stock issued upon redemption of convertible debt | |||||
| Cash and cash equivalents and restricted cash at end of the year | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other current assets | |||||
Loading...